LAVA Therapeutics NV Adjusted Weighted Average Shares
LAVA Therapeutics NV reported Adjusted Weighted Average Shares of 26.73 million shares for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-20.
Discontinued › Income Statement › Earnings Per Share
ifrs-full:AdjustedWeightedAverageShares · last filed 2024-03-20
| Period end | Adjusted Weighted Average Shares 12 month |
|---|---|
| 2023-12-31 | 26.73M shares 20-F · filed 2024-03-20 |
| 2022-12-31 | 25.92M shares 20-F · filed 2024-03-20 |
| 2021-12-31 | 19.76M shares 20-F · filed 2024-03-20 |
| 2020-12-31 | 399.13K shares 20-F · filed 2023-04-11 |
| 2019-12-31 | 447.52K shares 20-F/A · filed 2022-12-23 |